| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1042/CS20040370 |
| P698 | PubMed publication ID | 16104843 |
| P2093 | author name string | Masabumi Shibuya | |
| Hiroyuki Takahashi | |||
| P2860 | cites work | Regulation of endothelium-derived nitric oxide production by the protein kinase Akt | Q22010149 |
| Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation | Q22010150 | ||
| VEGF-D promotes the metastatic spread of tumor cells via the lymphatics | Q28200072 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 227-241 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Clinical Science | Q372419 |
| P1476 | title | The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions | |
| P478 | volume | 109 |
| Q27023870 | A Comprehensive and System Review for the Pharmacological Mechanism of Action of Rhein, an Active Anthraquinone Ingredient |
| Q36706461 | A Meta-Analysis of Studies Evaluating Visual and Anatomical Outcomes in Patients with Treatment Resistant Neovascular Age-Related Macular Degeneration following Switching to Treatment with Aflibercept |
| Q30439884 | A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap |
| Q38561314 | A placenta growth factor 2 variant acts as dominant negative of vascular endothelial growth factor A by heterodimerization mechanism. |
| Q30433214 | A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. |
| Q37400451 | ALS and oxidative stress: the neurovascular scenario |
| Q37419632 | Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle |
| Q39385904 | Activation of Dengue Virus-Specific T Cells Modulates Vascular Endothelial Growth Factor Receptor 2 Expression |
| Q30479159 | Adult stem cells and their trans-differentiation potential--perspectives and therapeutic applications |
| Q38049556 | Aflibercept for intravitreal injection: in neovascular age-related macular degeneration |
| Q91863172 | Alkaloid extract of Corydalis yanhusuo inhibits angiogenesis via targeting vascular endothelial growth factor receptor signaling |
| Q37287612 | An ezrin/calpain/PI3K/AMPK/eNOSs1179 signaling cascade mediating VEGF-dependent endothelial nitric oxide production |
| Q33689582 | Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells |
| Q37330675 | Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer |
| Q36268680 | Angiogenesis in implantation |
| Q37645436 | Angiogenesis in the atherosclerotic plaque. |
| Q38130312 | Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales |
| Q36928129 | Angiogenic factors and their soluble receptors predict organ dysfunction and mortality in post-cardiac arrest syndrome |
| Q45884628 | Angiogenic gene-modified myoblasts promote vascularization during repair of skeletal muscle defects |
| Q52151011 | Anti-Vascular Endothelial Growth Factor Treatment Suppresses Early Brain Injury After Subarachnoid Hemorrhage in Mice. |
| Q33713224 | Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice |
| Q45405723 | Antimicrobial peptide LL37 promotes vascular endothelial growth factor-A expression in human periodontal ligament cells |
| Q39519501 | Antivascular endothelial growth factor agents for neovascular age-related macular degeneration |
| Q42323537 | Aspalatone Prevents VEGF-Induced Lipid Peroxidation, Migration, Tube Formation, and Dysfunction of Human Aortic Endothelial Cells |
| Q36638595 | Association of -2549 insertion/deletion polymorphism of vascular endothelial growth factor with breast cancer in North Indian patients. |
| Q92680818 | Association of VEGFA and IL1β gene polymorphisms with preeclampsia in Sudanese women |
| Q37660950 | Association of a vascular endothelial growth factor polymorphism with the development of bronchopulmonary dysplasia in Japanese premature newborns |
| Q93067565 | Association study between the polymorphisms of angiogenesis-related genes and cervical cancer susceptibility in Chinese Uygur population |
| Q35049491 | Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta |
| Q64951363 | Behavior of Smooth Muscle Cells under Hypoxic Conditions: Possible Implications on the Varicose Vein Endothelium. |
| Q45919219 | Bevacizumab versus ranibizumab in the treatment of exudative age-related macular degeneration. |
| Q42139247 | Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab |
| Q38159735 | Bioactive lipids in pathological retinopathy |
| Q90155964 | Biochemical and Conformational Characterization of Recombinant VEGFR2 Domain 7 |
| Q38604899 | Biodegradable Carriers for Delivery of VEGF Plasmid DNA for the Treatment of Critical Limb Ischemia |
| Q38003860 | Biological, preclinical and clinical characteristics of inhibitors of vascular endothelial growth factors. |
| Q59808726 | Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients |
| Q34695003 | Biomarkers for anti-angiogenic therapy in cancer. |
| Q37695245 | Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells |
| Q34124396 | Blocking autocrine VEGF signaling by sunitinib, an anti-cancer drug, promotes embryonic stem cell self-renewal and somatic cell reprogramming |
| Q46433721 | Blood vessel formation during tail regeneration in the leopard gecko (Eublepharis macularius): The blastema is not avascular. |
| Q26826870 | Brain homeostasis: VEGF receptor 1 and 2-two unequal brothers in mind |
| Q51356864 | Branched-chain amino acid deficiency stabilizes insulin-induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells. |
| Q38056776 | Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome |
| Q37706317 | CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis |
| Q43061600 | Cardiovascular disease complications in systemic lupus erythematosus |
| Q39918362 | Catalyser-21(TM), a mineral water derived from leaf soil, inhibits tumor cell invasion and angiogenesis |
| Q57937606 | Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA |
| Q42044273 | Cellular and molecular mechanisms involved in the neuroprotective effects of VEGF on motoneurons. |
| Q37461446 | Changes in vascular endothelial growth factor (VEGF) induced by the Morris water maze task |
| Q33317046 | Cheiradone: a vascular endothelial cell growth factor receptor antagonist. |
| Q33894658 | Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat. |
| Q37156639 | Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance? |
| Q53655244 | Clinical efficacy of metronomic chemotherapy after cool-tip radiofrequency ablation in the treatment of hepatocellular carcinoma. |
| Q37961087 | Clinical implications of genetic variations in the VEGF system in relation to colorectal cancer. |
| Q39757470 | Cloning and expression of human vascular endothelial growth factor gene and inhibition of its expression by antisense in prokaryotic system. |
| Q38261105 | Complications of subspecialty ophthalmic care: systemic complications from the intravitreal administration of agents that target the vascular endothelial growth factor pathway. |
| Q92756232 | Compound C Inhibits B16-F1 Tumor Growth in a Syngeneic Mouse Model Via the Blockage of Cell Cycle Progression and Angiogenesis |
| Q90699218 | Comprehensive review of targeted therapy for colorectal cancer |
| Q30436024 | Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport |
| Q92541892 | Contribution of Angiogenesis to Inflammation and Cancer |
| Q33742723 | Cyclic stretch, reactive oxygen species, and vascular remodeling |
| Q91782048 | Defining the Inflammatory Microenvironment in the Human Cochlea by Perilymph Analysis: Toward Liquid Biopsy of the Cochlea |
| Q51830776 | Development of CE methods to analyze potential components of the angiogenic glycoprotein vascular endothelial growth factor 165. |
| Q42024507 | Development of a CE-MS method to analyze components of the potential biomarker vascular endothelial growth factor 165. |
| Q42406987 | Dextran sulfate sodium leads to chronic colitis and pathological angiogenesis in endoglin heterozygous mice |
| Q38542115 | Diabetic Retinopathy: Vascular and Inflammatory Disease. |
| Q89782757 | Differential Secretion of Angiopoietic Factors and Expression of MicroRNA in Umbilical Cord Blood from Healthy Appropriate-For-Gestational-Age Preterm and Term Newborns-in Search of Biomarkers of Angiogenesis-Related Processes in Preterm Birth |
| Q42030071 | Differential apicobasal VEGF signaling at vascular blood-neural barriers |
| Q34201006 | Differential expression of Vegfr-2 and its soluble form in preeclampsia |
| Q42132535 | Differential regulation of VEGF signaling by PKC-alpha and PKC-epsilon in endothelial cells |
| Q64989146 | Direct measurements of VEGF-VEGFR2 binding affinities reveal the coupling between ligand binding and receptor dimerization. |
| Q39584429 | Discovery of LY2457546: a multi-targeted anti-angiogenic kinase inhibitor with a novel spectrum of activity and exquisite potency in the acute myelogenous leukemia-Flt-3-internal tandem duplication mutant human tumor xenograft model. |
| Q46527823 | Distinct signaling pathways confer different vascular responses to VEGF 121 and VEGF 165. |
| Q34616563 | Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors |
| Q48261041 | Effect of intravitreal aflibercept (Eylea(®)) on retrobulbar hemodynamics in patients with neovascular age-related macular degeneration. |
| Q49667627 | Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy |
| Q43052752 | Effects of resveratrol on expression of vascular endothelial growth factor in human gingival fibroblasts stimulated by periodontal pathogens |
| Q38020128 | Effects of vascular endothelial growth factor in ischemic stroke |
| Q38304000 | Electroacupuncture suppresses myostatin gene expression: cell proliferative reaction in mouse skeletal muscle |
| Q64374719 | Endothelial FAM3A positively regulates post-ischaemic angiogenesis |
| Q37680222 | Endothelial and smooth muscle cells derived from human cardiac explants demonstrate angiogenic potential and suitable for design of cell-containing vascular grafts. |
| Q39924560 | Endotoxin-induced HIF-1alpha stabilisation in equine endothelial cells: synergistic action with hypoxia |
| Q34787415 | Engineered conformation-dependent VEGF peptide mimics are effective in inhibiting VEGF signaling pathways |
| Q37356898 | Evaluation of antiangiogenic and antiproliferative potential of the organic extract of green algae Chlorella pyrenoidosa |
| Q40745908 | Evaluation of circulating vascular endothelial growth factor and its soluble receptors in patients suffering from persistent allergic rhinitis |
| Q38795614 | Exosomes in stroke pathogenesis and therapy |
| Q90198339 | Expression and characterization of recombinant human VEGF165 in the middle silk gland of transgenic silkworms |
| Q46647666 | Expression of VEGF-A/C, VEGF-R2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma |
| Q33611056 | Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines |
| Q39958821 | Expression of vascular endothelial growth factor (VEGF)-B and its receptor (VEGFR1) in murine heart, lung and kidney |
| Q37267837 | Expressions of VEGF-A and VEGFR-2 in placentae from GDM pregnancies |
| Q59792865 | Extracellular Protein Fibulin-7 and Its C-Terminal Fragment Have In Vivo Antiangiogenic Activity |
| Q43239279 | Fetal adrenal gland alterations in a rat model of adverse intrauterine environment |
| Q50541802 | Gene delivery of soluble vascular endothelial growth factor receptor-1 (sFlt-1) inhibits intra-plaque angiogenesis and suppresses development of atherosclerotic plaque |
| Q38654588 | Gene therapy for age-related macular degeneration. |
| Q58362653 | Gene therapy in peripheral artery disease |
| Q55452882 | Gene-Therapeutic Strategies Targeting Angiogenesis in Peripheral Artery Disease. |
| Q83715974 | Genetic variants on chromosome 6p21.1 and 6p22.3 are associated with type 2 diabetes risk: a case-control study in Han Chinese |
| Q35912389 | Genetic variation in VEGF family genes and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study |
| Q41423380 | Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea. |
| Q34335643 | Gram-positive pathogenic bacteria induce a common early response in human monocytes |
| Q37676697 | Growth factors as active participants in carcinogenesis: a perspective |
| Q46819215 | Helical peptides from VEGF and Vammin hotspots for modulating the VEGF-VEGFR interaction. |
| Q36524769 | Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma |
| Q37398294 | Heterozygous disruption of Flk-1 receptor leads to myocardial ischaemia reperfusion injury in mice: application of affymetrix gene chip analysis |
| Q54631831 | Hippocampal Neurogenesis after Traumatic Brain Injury Is Mediated by Vascular Endothelial Growth Factor Receptor-2 and the Raf/MEK/ERK Cascade |
| Q36431941 | How useful is the assessment of lymphatic vascular density in oral carcinoma prognosis? |
| Q43713556 | Human mature endothelial cells modulate peripheral blood mononuclear cell differentiation toward an endothelial phenotype. |
| Q91522755 | Hydrostatic pressure promotes endothelial tube formation through aquaporin 1 and Ras-ERK signaling |
| Q81892999 | Immunoexpression of vascular endothelial growth factor in periapical granulomas, radicular cysts, and residual radicular cysts |
| Q45905279 | Immunohistochemical correlation between microvessel density and lymphoid infiltrate in radicular cysts. |
| Q41852551 | Immunohistochemical expression of vascular endothelial growth factor and matrix metalloproteinase-9 in radicular and residual radicular cysts |
| Q35628369 | Increased expression of vascular endothelial growth factor in neo-vascularized canine brain tissue |
| Q36394290 | Increased plasma concentration of vascular endothelial growth factor in patients with atopic dermatitis and its relation to disease severity and platelet activation |
| Q35089453 | Inflammation-induced endothelial cell-derived extracellular vesicles modulate the cellular status of pericytes |
| Q48581073 | Influence of vascular endothelial growth factor and Cysteamine on in vitro bovine oocyte maturation and subsequent embryo development. |
| Q36764876 | Inhibiting kinases in malignant gliomas |
| Q37031073 | Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function |
| Q45783799 | Inhibition of p38 MAPK reduces expression of vascular endothelial growth factor in allergic airway disease |
| Q39594949 | Inhibitory effect of curcumin on oral carcinoma CAL-27 cells via suppression of Notch-1 and NF-κB signaling pathways |
| Q30437740 | Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapy |
| Q38591546 | Intercellular communication lessons in heart failure |
| Q36918194 | Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells. |
| Q41902127 | Intravitreal injection of ranibizumab and CTGF shRNA improves retinal gene expression and microvessel ultrastructure in a rodent model of diabetes |
| Q37135388 | Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy |
| Q35145097 | Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia |
| Q42415885 | Ischemia-reperfusion injury induces occludin phosphorylation/ubiquitination and retinal vascular permeability in a VEGFR-2-dependent manner |
| Q39415018 | KMUP-1 inhibits H441 lung epithelial cell growth, migration and proinflammation via increased NO/CGMP and inhibited RHO kinase/VEGF signaling pathways |
| Q34552843 | KRIT1 protein depletion modifies endothelial cell behavior via increased vascular endothelial growth factor (VEGF) signaling |
| Q26822766 | Keratinocytic vascular endothelial growth factor as a novel biomarker for pathological skin condition |
| Q38008362 | Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following Transplantation |
| Q35760920 | Knockdown of VEGF receptor-1 (VEGFR-1) impairs macrophage infiltration, angiogenesis and growth of clear cell renal cell carcinoma (CRCC). |
| Q51838560 | Kolaviron improved resistance to oxidative stress and inflammation in the blood (erythrocyte, serum, and plasma) of streptozotocin-induced diabetic rats. |
| Q46061181 | L-Arginine promotes angiogenesis in the chronically hypoxic lung: a novel mechanism ameliorating pulmonary hypertension. |
| Q34338215 | Malignant pericardial effusion |
| Q42080378 | Mast Cell-Intervertebral disc cell interactions regulate inflammation, catabolism and angiogenesis in Discogenic Back Pain |
| Q35716176 | Maternal Smoking History Enhances the Expression of Placental Growth Factor in Invasive Trophoblasts at Early Gestation Despite Cessation of Smoking |
| Q46928117 | Matrix metalloproteinases and vascular endothelial growth factor expression in canine leukaemias |
| Q38953207 | Mechanical forces induce changes in VEGF and VEGFR-1/sFlt-1 expression in human chondrocytes. |
| Q37956587 | Mechanisms of resistance to vascular endothelial growth factor blockade |
| Q37678807 | Mediators of ocular angiogenesis |
| Q37236004 | Metronomic chemotherapy: possible clinical application in advanced hepatocellular carcinoma |
| Q28395657 | MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90/vascular endothelial growth factor A axis |
| Q38874739 | Microvascular density and immunohistochemical expression of VEGF, VEGFR-1 and VEGFR-2 in benign prostatic hyperplasia, high-grade prostate intraepithelial neoplasia and prostate cancer |
| Q41847558 | Modified rice bran hemicellulose inhibits vascular endothelial growth factor-induced angiogenesis in vitro via VEGFR2 and its downstream signaling pathways |
| Q36710448 | Modulation of vascular endothelial growth factor (VEGF) expression in motor neurons and its electrophysiological effects |
| Q50423780 | Molecular Regulation of Sprouting Angiogenesis |
| Q42121924 | Molecular and clinical aspects of targeting the VEGF pathway in tumors. |
| Q34566028 | Molecular and functional diversity of vascular endothelial growth factors |
| Q34089123 | Molecular diversity of VEGF-A as a regulator of its biological activity. |
| Q36279449 | Morphological Plasticity of Emerging Purkinje Cells in Response to Exogenous VEGF |
| Q38304336 | NKCC1 mediates traumatic brain injury-induced hippocampal neurogenesis through CREB phosphorylation and HIF-1α expression. |
| Q33921294 | NKX2-3 transcriptional regulation of endothelin-1 and VEGF signaling in human intestinal microvascular endothelial cells |
| Q41825489 | Nanoglycan complex formulation extends VEGF retention time in the lung |
| Q90469422 | Network Pharmacology Analysis of Traditional Chinese Medicine Formula Xiao Ke Yin Shui Treating Type 2 Diabetes Mellitus |
| Q43458281 | Neuroprotective effect of melatonin against hypoxia-induced retinal ganglion cell death in neonatal rats |
| Q34474159 | New Insights into VEGF-A Alternative Splicing: Key Regulatory Switching in the Pathological Process |
| Q38308502 | Non-competitive aptamer-based quenching resonance energy transfer assay for homogeneous growth factor quantification. |
| Q34947216 | Novel VEGF decoy receptor fusion protein conbercept targeting multiple VEGF isoforms provide remarkable anti-angiogenesis effect in vivo |
| Q58800992 | Onset and Progression of Human Osteoarthritis-Can Growth Factors, Inflammatory Cytokines, or Differential miRNA Expression Concomitantly Induce Proliferation, ECM Degradation, and Inflammation in Articular Cartilage? |
| Q100490609 | Overview of current targeted therapy in gallbladder cancer |
| Q42437368 | Parathyroid hormone-related protein interacts with vascular endothelial growth factor to promote fibrogenesis in the obstructed mouse kidney |
| Q39258872 | Pathogenesis of vascular leak in dengue virus infection |
| Q42369962 | Pathogenic CD8+ T Cells Cause Increased Levels of VEGF-A in Experimental Malaria-Associated Acute Respiratory Distress Syndrome, but Therapeutic VEGFR Inhibition Is Not Effective |
| Q26865897 | Pathophysiology of diabetic retinopathy |
| Q30437439 | Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF. |
| Q47803418 | Pediatric brain repair from endogenous neural stem cells of the subventricular zone |
| Q39468924 | Perfluorocarbon emulsions prevent hypoxia of pancreatic β-cells. |
| Q37828119 | Pigment epithelium-derived factor as an impending therapeutic agent against vascular epithelial growth factor-driven tumor-angiogenesis. |
| Q35884170 | Placental Underperfusion in a Rat Model of Intrauterine Growth Restriction Induced by a Reduced Plasma Volume Expansion |
| Q53093520 | Platelet-Rich Plasma in a Murine Model: Leukocytes, Growth Factors, Flt-1, and Muscle Healing. |
| Q92070082 | Platelet-rich plasma as a site-targeted approach in wound healing: a molecular perspective |
| Q41473406 | Poly-γ-glutamic acid attenuates angiogenesis and inflammation in experimental colitis. |
| Q33646077 | Prognostic Value of Vascular Endothelial Growth Factor A in the Prediction of the Tumor Aggressiveness in Clear Cell Renal Cell Carcinoma |
| Q35480244 | Prognostic role of vascular endothelial growth factor in prostate cancer: a systematic review and meta-analysis |
| Q36894556 | Progress in defining the molecular biology of age related macular degeneration |
| Q36787218 | Promise of multiphoton detection in discovery and diagnostic proteomics |
| Q55386583 | Prostaglandin F-2α Stimulates The Secretion of Vascular Endothelial Growth Factor and Induces Cell Proliferation and Migration of Adipose Tissue Derived Mesenchymal Stem Cells. |
| Q38094076 | Ranibizumab: a review of its use in the treatment of neovascular age-related macular degeneration |
| Q36627279 | Ranibizumab: treatment in patients with neovascular age-related macular degeneration |
| Q53576295 | Rapid onset of gene expression in lung, supportive of formation of alveolar septa, induced by refeeding mice after calorie restriction. |
| Q91239698 | Real-time in vivo two-photon imaging study reveals decreased cerebro-vascular volume and increased blood-brain barrier permeability in chronically stressed mice |
| Q37760097 | Recent concepts of antiangiogenic therapy |
| Q26751331 | Recent developments in receptor tyrosine kinases targeted anticancer therapy |
| Q39456719 | Regulation of Vegf signaling by natural and synthetic ligands |
| Q99605264 | Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets |
| Q34525985 | Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies |
| Q38212662 | Roles of VEGF-A signalling in development, regeneration, and tumours |
| Q47116461 | Roles of VEGF-Flt-1 signaling in malignant behaviors of oral squamous cell carcinoma. |
| Q33616384 | Roles of vascular endothelial growth factor in amyotrophic lateral sclerosis |
| Q38734446 | Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants. |
| Q40144966 | Selective inhibition of plasma membrane calcium ATPase 4 improves angiogenesis and vascular reperfusion |
| Q24617241 | Semaphorin-PlexinD1 signaling limits angiogenic potential via the VEGF decoy receptor sFlt1 |
| Q48545238 | Serum VEGF levels in acute ischaemic strokes are correlated with long-term prognosis |
| Q55011252 | Serum VEGF levels in the early diagnosis and severity assessment of non-small cell lung cancer. |
| Q36956283 | Serum level of vascular endothelial growth factor decreased in chronic ketamine abusers |
| Q89495793 | Sevoflurane promotes the proliferation of HUVECs by activating VEGF signaling |
| Q64991000 | SiRNA silencing of VEGF, IGFs, and their receptors in human retinal microvascular endothelial cells. |
| Q59381645 | Sjögren’s syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB |
| Q63990343 | Smad signal pathway regulates angiogenesis via endothelial cell in an adipose-derived stromal cell/endothelial cell co-culture, 3D gel model |
| Q54648907 | Soluble receptors for vascular endothelial growth factor (sVEGFR1/sVEGFR2) in infantile hemangioma |
| Q39126237 | Statins in conditions other than hypocholesterolemic effects for chronic subdural hematoma therapy, old drug, new tricks? |
| Q33434180 | Stilbene glycosides are natural product inhibitors of FGF-2-induced angiogenesis. |
| Q28487616 | Structural characterization of a recombinant fusion protein by instrumental analysis and molecular modeling |
| Q90450692 | Study on the correlation and predictive value of serum pregnancy-associated plasma protein A, triglyceride and serum 25-hydroxyvitamin D levels with gestational diabetes mellitus |
| Q34798203 | Substantial neuroprotection against K+ deprivation-induced apoptosis in primary cerebellar granule neurons by novel dimer bis(propyl)-cognitin via the activation of VEGFR-2 signaling pathway |
| Q35783198 | Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity |
| Q36200700 | Systematic evaluation of natural scaffolds in cutaneous wound healing |
| Q34452811 | Systemic safety of anti-VEGF drugs: a commentary |
| Q38032311 | Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration |
| Q38210239 | Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview. |
| Q30438979 | Systems biology of vascular endothelial growth factors |
| Q35815609 | TGFβ signalling pathway regulates angiogenesis by endothelial cells, in an adipose-derived stromal cell/endothelial cell co-culture 3D gel model |
| Q46621277 | TNF-α and LPS activate angiogenesis via VEGF and SIRT1 signalling in human dental pulp cells |
| Q60047642 | TRP Channels in Angiogenesis and Other Endothelial Functions |
| Q55128284 | Targeting Splicing in Prostate Cancer. |
| Q33387704 | The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer |
| Q97547928 | The Bartonella autotransporter BafA activates the host VEGF pathway to drive angiogenesis |
| Q54636138 | The Bartonella henselae VirB/Bep system interferes with vascular endothelial growth factor (VEGF) signalling in human vascular endothelial cells. |
| Q36144280 | The JAK/STAT3 signalling pathway regulated angiogenesis in an endothelial cell/adipose-derived stromal cell co-culture, 3D gel model. |
| Q55398453 | The Novel Pathogenesis of Retinopathy Mediated by Multiple RTK Signals is Uncovered in Newly Developed Mouse Model. |
| Q37636781 | The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance. |
| Q35647966 | The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancy |
| Q39787486 | The balance of autocrine VEGF-A and VEGF-C determines podocyte survival |
| Q26796921 | The cellular response to vascular endothelial growth factors requires co-ordinated signal transduction, trafficking and proteolysis |
| Q34245619 | The discovery of placenta growth factor and its biological activity. |
| Q44309209 | The dynamics of angiogenic factors and their soluble receptors in relation to organ dysfunction in disseminated intravascular coagulation associated with sepsis |
| Q38103868 | The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy |
| Q35501083 | The effect of vascular endothelial growth factor on osteoclastogenesis in rheumatoid arthritis |
| Q80517364 | The immunohistochemical analysis of vascular endothelial growth factors A and C and microvessel density in gingival tissues of systemic sclerosis patients: their possible effects on gingival inflammation |
| Q84880225 | The importance of -460 C/T and +405 G/C single nucleotide polymorphisms to the function of vascular endothelial growth factor A in colorectal cancer |
| Q37263382 | The osteogenic-angiogenic interface: novel insights into the biology of bone formation and fracture repair |
| Q37334240 | The prognostic value of haplotypes in the vascular endothelial growth factor a gene in colorectal cancer |
| Q36390431 | The role of VEGF receptors in angiogenesis; complex partnerships |
| Q48895465 | The role of VEGF/VEGFR2 signaling in peripheral stimulation-induced cerebral neurovascular regeneration after ischemic stroke in mice |
| Q26798348 | The role of aflibercept in the management of diabetic macular edema |
| Q36616721 | The role of angiogenic factors and their soluble receptors in acute lung injury (ALI)/ acute respiratory distress syndrome (ARDS) associated with critical illness |
| Q100523503 | The role of the PlGF/Flt-1 signaling pathway in the cardiorenal connection |
| Q37418939 | The role of vascular endothelial growth factor in metastatic prostate cancer to the skeleton |
| Q35618768 | Therapeutic Angiogenesis by Gene Therapy for Critical Limb Ischemia: Choice of Biological Agent |
| Q39731093 | Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair |
| Q42115589 | Thrombin-induced VEGF expression in human retinal pigment epithelial cells |
| Q37718435 | Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model |
| Q42548913 | Time-dependent changes of plasma concentrations of angiopoietins, vascular endothelial growth factor, and soluble forms of their receptors in nonsmall cell lung cancer patients following surgical resection |
| Q37420851 | Transcriptional profiling of hilar nodes from pigs after experimental infection with Actinobacillus pleuropneumoniae |
| Q27329613 | Transmigration of neural stem cells across the blood brain barrier induced by glioma cells |
| Q37233230 | Treatment of age-related macular degeneration: focus on ranibizumab |
| Q42864506 | Tyrosine phosphorylation modulates the vascular responses of mesenteric arteries from human colorectal tumors. |
| Q36925848 | Using angiogenic factors and their soluble receptors to predict organ dysfunction in patients with disseminated intravascular coagulation associated with severe trauma |
| Q38681382 | VEGF Expression in Pancreatic Cancer and Other Malignancies: A Review of the Literature |
| Q92409844 | VEGF Induce Vasculogenic Mimicry of Choroidal Melanoma through the PI3k Signal Pathway |
| Q35980480 | VEGF Receptor-2-Linked PI3K/Calpain/SIRT1 Activation Mediates Retinal Arteriolar Dilations to VEGF and Shear Stress |
| Q39910127 | VEGF and Bcl-2 interact via MAPKs signaling pathway in the response to hypoxia in neuroblastoma |
| Q42099822 | VEGF and Notch in tip and stalk cell selection |
| Q30432040 | VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model |
| Q36485145 | VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine |
| Q100415976 | VEGF knockdown enhances radiosensitivity of nasopharyngeal carcinoma by inhibiting autophagy through the activation of mTOR pathway |
| Q37848687 | VEGF non-angiogenic functions in adult organ homeostasis: therapeutic implications |
| Q81326073 | VEGF receptor inhibition slows the progression of polycystic kidney disease |
| Q29617256 | VEGF receptor signalling - in control of vascular function |
| Q45257013 | VEGF-B Levels in the Vitreous of Diabetic and Non-Diabetic Patients with Ocular Diseases and Its Correlation with Structural Parameters |
| Q39519666 | VEGF-C differentially regulates VEGF-A expression in ocular and cancer cells; promotes angiogenesis via RhoA mediated pathway |
| Q41900132 | VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2 |
| Q91405026 | VEGF/Flk1 Mechanism is Involved in Roxarsone Promotion of Rat Endothelial Cell Growth and B16F10 Xenograft Tumor Angiogenesis |
| Q37397851 | VEGFR-1 regulates adult olfactory bulb neurogenesis and migration of neural progenitors in the rostral migratory stream in vivo |
| Q36791927 | VEGFR-2 conformational switch in response to ligand binding. |
| Q55021686 | Vascular Endothelial Growth Factor Gene Polymorphism Is Associated With Long-term Kidney Allograft Outcomes. |
| Q42950906 | Vascular endothelial growth factor (VEGF) and VEGF-receptor expression in placenta of hyperglycemic pregnant women |
| Q35762769 | Vascular endothelial growth factor biology: clinical implications for ocular treatments |
| Q91362469 | Vascular endothelial growth factor enhances profibrotic activities through modulation of calcium homeostasis in human atrial fibroblasts |
| Q37010405 | Vascular endothelial growth factor in astroglioma stem cell biology and response to therapy |
| Q36929380 | Vascular endothelial growth factor in eye disease |
| Q83389364 | Vascular endothelial growth factor in malignant and benign pericardial effusion |
| Q34910747 | Vascular endothelial growth factor levels in gingival crevicular fluid before and after periodontal therapy |
| Q45990804 | Vascular endothelial growth factor mRNA expression and peritumoral edema in canine primary central nervous system tumors. |
| Q36400129 | Vascular endothelial growth factors and their inhibitors in ocular neovascular disorders |
| Q27028225 | Vitreous mediators in retinal hypoxic diseases |
| Q42234877 | Vulnerability of primary neurons derived from Tg2576 Alzheimer mice to oxygen and glucose deprivation: role of intraneuronal amyloid-β accumulation and astrocytes. |
| Q45931894 | [MMP- and FAP-mediated non-inflammation-related destruction of cartilage and bone in rheumatoid arthritis]. |
| Q35539017 | mRNA expression of VEGF and its receptors in fallopian tubes of women with ectopic pregnancies |
| Q33802900 | miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer |
| Q39303204 | β-catenin involvement in arsenite-induced VEGF expression in neuroblastoma SH-SY5Y cells |
Search more.